Jacob E. Shabason

3.3k total citations
45 papers, 1.3k citations indexed

About

Jacob E. Shabason is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jacob E. Shabason has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 9 papers in Surgery. Recurrent topics in Jacob E. Shabason's work include Sarcoma Diagnosis and Treatment (14 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jacob E. Shabason is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jacob E. Shabason collaborates with scholars based in United States, Germany and Canada. Jacob E. Shabason's co-authors include Andy J. Minn, Kevin Camphausen, Philip J. Tofilon, Yu Qiu, Barzin Y. Nabet, Julia Tchou, Joseph L. Benci, Angela DeMichele, Taewon Yoon and Tony J. Wu and has published in prestigious journals such as Cell, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Jacob E. Shabason

44 papers receiving 1.3k citations

Peers

Jacob E. Shabason

ONCOL

PRM

IMMUN

Dennis P.M. Hughes United States

Fionnuala O’Connell Ireland

Hirofumi Koike Japan

Diana Romero United States

Jun Zhu China

David Nicol Australia

Danhua Shen China

Giovanna Masci Italy

Moritz von Winterfeld Germany

Joseph G. Pressey United States

Dennis P.M. Hughes United States

Jacob E. Shabason

770 ×1.2

481 ×1.3

ONCOL

447 ×1.3

PRM

396 ×1.2

235 ×1.2

IMMUN

Citations per year, relative to Jacob E. Shabason Jacob E. Shabason (= 1×) peers Dennis P.M. Hughes

Countries citing papers authored by Jacob E. Shabason

Since Specialization

Citations

This map shows the geographic impact of Jacob E. Shabason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Shabason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Shabason more than expected).

Fields of papers citing papers by Jacob E. Shabason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob E. Shabason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Shabason. The network helps show where Jacob E. Shabason may publish in the future.

Co-authorship network of co-authors of Jacob E. Shabason

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob E. Shabason. A scholar is included among the top collaborators of Jacob E. Shabason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob E. Shabason. Jacob E. Shabason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dastgheyb, Sana, Michael J. LaRiviere, Jahan J. Mohiuddin, et al.. (2024). A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas. Advances in Radiation Oncology. 9(5). 101456–101456. 5 indexed citations

Smith, Benjamin D., Ethan B. Ludmir, Daniel V. Wakefield, et al.. (2022). Predicting future cancer incidence by age, race, ethnicity, and sex. Journal of Geriatric Oncology. 14(1). 101393–101393. 29 indexed citations

Valle, Luca, Nicholas M. Bernthal, Fritz C. Eilber, et al.. (2021). Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma. Sarcoma. 2021. 1–8. 6 indexed citations

Miranda, Stephen P., Steven Brem, Donald M. O’Rourke, et al.. (2021). Resecting the dominant lesion: Patient outcomes after surgery and radiosurgery vs stand-alone radiosurgery in the setting of multiple brain metastases. Clinical Neurology and Neurosurgery. 211. 107016–107016. 2 indexed citations

Reddy, Vishruth K., Varsha Jain, Lee Hartner, et al.. (2021). Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database. Sarcoma. 2021. 1–11. 1 indexed citations

Mohiuddin, Jahan J., Brian Chu, Andrea Facciabene, et al.. (2020). Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 113(2). 162–170. 96 indexed citations

Verma, Vivek, J. Isabelle Choi, Jacob E. Shabason, et al.. (2018). Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States. Clinical Lung Cancer. 19(5). e685–e692. 18 indexed citations

Venigalla, Sriram, David Guttmann, Varsha Jain, et al.. (2018). Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis. Clinical Breast Cancer. 18(5). e899–e908. 16 indexed citations

Venigalla, Sriram, Amit K. Chowdhry, Andrzej P. Wojcieszynski, et al.. (2018). Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer. Clinical Colorectal Cancer. 17(3). e557–e568. 2 indexed citations

10.

Wojcieszynski, Andrzej P., Craig R. Hullett, Neil K. Taunk, et al.. (2018). The role of radiation therapy in the treatment of Stage II endometrial cancer: A large database study. Brachytherapy. 17(4). 645–652. 7 indexed citations

11.

Verma, Vivek, Christopher Ahern, William D. Lindsay, et al.. (2018). Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival. Clinical Lung Cancer. 19(6). e901–e912. 40 indexed citations

12.

LeBrun, Drake G., David Guttmann, Jacob E. Shabason, et al.. (2017). Predictors of Wound Complications following Radiation and Surgical Resection of Soft Tissue Sarcomas. Sarcoma. 2017. 1–7. 27 indexed citations

13.

Shabason, Jacob E. & Andy J. Minn. (2017). Radiation and Immune Checkpoint Blockade: From Bench to Clinic. Seminars in Radiation Oncology. 27(3). 289–298. 34 indexed citations

14.

Sharma, Sonam, Matthew T. McMillan, Abigail Doucette, et al.. (2017). Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Clinical Lung Cancer. 19(3). 260–269.e3. 20 indexed citations

15.

Verma, Vivek, Christopher Ahern, William D. Lindsay, et al.. (2017). National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(11). 1704–1714. 60 indexed citations

16.

Nabet, Barzin Y., Yu Qiu, Jacob E. Shabason, et al.. (2017). Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer. Cell. 170(2). 352–366.e13. 354 indexed citations

17.

Arscott, W. Tristram, Anita Tandle, Shuping Zhao, et al.. (2013). Ionizing Radiation and Glioblastoma Exosomes: Implications in Tumor Biology and Cell Migration. Translational Oncology. 6(6). 638–IN6. 191 indexed citations

18.

Shabason, Jacob E., Philip J. Tofilon, & Kevin Camphausen. (2011). Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic. Journal of Cellular and Molecular Medicine. 15(12). 2735–2744. 71 indexed citations

19.

Seet, Bruce T., Donna M. Berry, Jonathan S. Maltzman, et al.. (2007). Efficient T‐cell receptor signaling requires a high‐affinity interaction between the Gads C‐SH3 domain and the SLP‐76 RxxK motif. The EMBO Journal. 26(3). 678–689. 34 indexed citations

20.

Jordan, Martha S., Jonathan S. Maltzman, Stefanie Kliche, et al.. (2007). In vivo disruption of T cell development by expression of a dominant‐negative polypeptide designed to abolish the SLP‐76/Gads interaction. European Journal of Immunology. 37(10). 2961–2972. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact